Artiva Biotherapeutics, Inc. ARTV Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating lease liability payments due?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease liability payments due of $11.68M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease liability payments due changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease liability payments due decreased by 29.4% year-over-year, from $16.53M to $11.68M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.